Towa Pharmaceutical Co., Ltd.

4553.T · JPX
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income¥19¥16¥5¥22
Dep. & Amort.¥20¥18¥19¥11
Deferred Tax¥0¥0¥0¥0
Stock-Based Comp.¥0¥0¥0¥0
Change in WC-¥11-¥27-¥14-¥3
Other Non-Cash-¥5¥1-¥8-¥8
Operating Cash Flow¥23¥8¥3¥22
Investing Activities
PP&E Inv.-¥31-¥38-¥30-¥14
Net Acquisitions¥0-¥2-¥1-¥45
Inv. Purchases-¥0-¥0-¥0-¥0
Inv. Sales/Matur.¥0¥0¥0¥0
Other Inv. Act.¥0-¥1¥2-¥1
Investing Cash Flow-¥31-¥40-¥30-¥60
Financing Activities
Debt Repay.¥24¥39¥21¥49
Stock Issued¥0¥0¥0¥0
Stock Repurch.¥0¥0¥0¥0
Dividends Paid-¥3-¥3-¥3-¥2
Other Fin. Act.¥0-¥0-¥0-¥0
Financing Cash Flow¥22¥35¥17¥47
Forex Effect¥2¥2¥2¥1
Net Chg. in Cash¥16¥5-¥9¥10
Supplemental Information
Beg. Cash¥30¥24¥33¥23
End Cash¥45¥30¥24¥33
Free Cash Flow-¥5-¥31-¥28¥9